BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Prostate
,
Amniocentesis
,
Valproic acid
,
rs6983267
,
IGF1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
L-DOPA
Summary
General Info
Curated Studies
Most Correlated Studies
Drd2 and Drd1a spiny projection neurons parkinsonian treated with high and low dose DOPA
Striata of rats with Parkinson's disease after zonisamide and levodopa treatment
Striata of parkinsonian rats with subthalamic nucleus high frequency stimulation (STN-HFS)
Dopamine Signaling in Parkinson disease model
Explore Curated Studies Results
Literature
Most Relevant Literature
L-DOPA Autoxidation: An Empirical Valence Bond Simulation of the Reactive Step.
Quantum-level machine learning calculations of Levodopa.
Machine-learning model for the prediction of acute orthostatic hypotension after levodopa administra…
Eumelanin-like Poly(levodopa) Nanoscavengers for Inflammation Disease Therapy.
Instrumented timed up and go test and machine learning-based levodopa response evaluation: a pilot s…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Antipsychotic Augmentation With L-Dopa
Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Pa…
A Study of L-DOPA for Depression and Slowing in Older Adults
Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients…
Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ